NeuroMetrix Quell™ Wearable Pain Relief Technology Attracts Attention at CES.
NeuroMetrix, Inc. unveiled a brand new wearable technology in the digital health field – Quell. Quell is a non-invasive neurostimulation technology that helps to provide relief from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. Users of the device will also have the option of using their smartphone to automatically track and personalize their pain therapy. It is intended to help people who suffer from pain due to conditions such as diabetes, sciatica, fibromyalgia and degenerative knee conditions.
Quell was designed with the user in mind and meant to be comfortable and wearable throughout the day. It appears to be very small and discreet. The technology behind Quell calibrates to your optimal stimulation level to ensure you receive maximum relief. The device will automatically adjust to your needs depending on the time of day and it sense when you are lying down, too.
Quell is rechargable and provides up to 40 hours of continuous pain relief on a single charge. Perhaps the coolest part of this device is the control you can have over your own care through your smart phone. Quell connects to your iOS device to track your therapy and sleep quality.
Quell’s therapy is basically electronic stimulation and TENS devices have been around for quite some time. So, how is it different? Quell’s proven neurotechnology is double the strength of other products on the market today, enabling the device to trigger systemic pain relief that covers other areas of your body.
This device stands to really help a lot of people in pain. I am looking forward to taking a closer look at it when it is available. Pre-orders will begin in March with the units shipping during the second quarter. It’s anticipated to sell for around $250. Quell will initially be available exclusively through doctor’s offices and online.